Errors in Table 1 - Report - MDSpire

Errors in Table 1

  • July 14, 2026

Share

Corrections to Data Presented in Table 1

Background

Accurate data presentation is critical in clinical research, particularly in studies assessing treatment outcomes for major depressive disorder.

Data Highlights

No numerical data is presented in the source material, but corrections were made to the figures for yearly participant and household income and duration since diagnosis.

Key Findings

  • The original investigation's data in Table 1 was incorrectly derived using the SPSS 'HAVERAGE' technique.
  • The corrected figures now reflect straightforward non-interpolated techniques.
  • These corrections pertain to yearly participant and household income and duration since diagnosis.
  • The article has been amended to reflect these changes.

Clinical Implications

Healthcare professionals should be aware of the importance of data accuracy in clinical studies.

Conclusion

The amendments to the data presented in the original investigation were made to ensure accurate reporting.

Related Resources & Content

  1. JAMA Network, JAMA Network Open, 2025 -- Measurement-Based Care to Enhance Antidepressant Treatment Outcomes in Major Depressive Disorder: A Randomized Clinical Trial
  2. JAMA Network, JAMA Network Open, 2025 -- Errors in Table 1
  3. Erratum: Compliance with Multi-Target Stool DNA Testing for Colorectal Cancer Screening in the U.S.
  4. Acta Neuropathologica — Erratum: Seeding Activity of Transmissible α‑Synuclein in the Brain and Stomach of Individuals with Parkinson’s Disease
  5. Pediatric Cardiology — Correction: Navigating the Shift from In-Utero Safety to External Environment for Infants with Critical Cardiovascular Disorders: The IMmediate Postpartum Access to Cardiac Therapy (IMPACT) Approach
  6. Infection — Erratum: Patterns of Mortality Following Sepsis Hospitalization: Insights from a Nationwide Prospective Registry Analysis (2008-2021)
  7. VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (MDD)
  8. CCBHC Quality Measures Guidance and Webinar Series | SAMHSA
  9. Implementation of Measurement-Based Care in Mental Health Services: A Systematic Literature Review | Psychiatric Services
  10. Measurement-Based Care to Enhance Antidepressant Treatment Outcomes in Major Depressive Disorder: A Randomized Clinical Trial | Trials | JAMA Network Open | JAMA Network
  11. Errors in Table 1 | JAMA Network Open | JAMA Network
  12. Remote Measurement-Based Care Interventions for Mental Health: Systematic Review and Meta-Analysis - PubMed
  13. Frontiers | The impact of measurement based care at scale: examining the effects of implementation on patient outcomes and provider behaviors

Original Source(s)

Errors in Table 1

  • July 14, 2026

Related Content

FDA Approves At-Home Starting Dose for Lecanemab

Patients may begin lecanemab-irmb treatment at home through self-administration or administration by a caregiver, according to the FDA.

10 CMS and FDA Actions Affecting Care in 2026

From Medicare payment updates to drug approvals and device access, these federal actions may affect reimbursement, prescribing, patient access, and clinical workflows.

Case Report: A novel de novo heterozygous truncating mutation in MED12L identified in a Chinese autistic boy